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Ewing’s sarcoma is the second most common malignant bone cancer found in 
adolescents, and the genetic hallmark of this disease is the presence of the aberrant chimeric 
fusion protein EWS/FLI1. This fusion is induced by the t(11; 22) chromosomal translocation of 
EWS and FLI1, and is the most prominent and common characteristic of Ewing sarcoma tumors 
found in approximately 85-90% of reported cases. EWS/FLI1 has been shown to directly bind to 
and inhibit the function of endogenous EWS in a dominant manner. In this study, we seek to 
increase our understanding of the role of endogenous EWS during development and 
skeletogenesis to gain insight into the pathogenesis of the disease. Previously, we demonstrated 
the role of a zebrafish EWS homolog Ewsa by analyzing the phenotype of a maternal zygotic 
homozygous ewsa/ewsa mutant line (MZ ewsa/ewsa) of zebrafish null for Ewsa protein.  
Prehypertrophic chondrocytes of Meckel’s cartilage in 4dpf MZ ewsa/ewsa mutants fail to 
completely differentiate into hypertrophic chondrocytes, followed by structural defects in 
craniofacial bones (dentary and basihyal bones) at the adult stage. Based on these results, we 
sought to understand EWS’s involvement in skeletogenesis by asking if Ewsa regulates activity 
of critical transcription factors involved in chondrocyte development. We have previously shown 
that Ewsa directs chondrocyte differentiation through modulation of chondrogenesis master 
transcription factor Sox9. Runx2 is also known to play a critical role in differentiation of both 
chondrocytes and osteoblasts, so we have addressed whether and how Ewsa regulates Runx2 
expression and transcriptional activity. We discovered that Runx2 protein expression dramatically 
increases in craniofacial chondrocytes of 4-6dpf MZ ewsa/ewsa compared to wt/wt embryos. We 
have also observed premature mineralization in MZ ewsa/ewsa embryos at 6dpf and 10dpf. MZ 
ewsa/ewsa fish also display a decrease in expression of collagen10a1, a hypertrophic-specific 
Runx2 target gene. These data together suggests that Ewsa regulates Runx2 expression and 
transcriptional activity during chondrogenesis and regulates mineralization of these domains. 
Additionally, our lab has previously discovered that adult MZ ewsa/ewsa fish display aberrant 
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curved spines. Based on these results we asked how Ewsa is involved in the formation of the 
axial skeleton. Since Collagen2a1 is a critical component of notochord development as both a 
precursor to intervertebral disc (IVD) formation and as a component of notochord sheath 
extracellular matrix (ECM) we have previously asked if Ewsa regulates the collagen2a1a gene. 
Ewsa interacts with the col2a1a gene and col2a1 is upregulated in the notochord MZ ewsa/ewsa 
fish which suggests that the notochord sheath ECM is misregulated in mutant fish. Additionally, 
our analysis also revealed that notochord cells have failed to intercalate 5-10dpf and remain in a 
single layer. Based on our previous data and the data in this report, we hypothesize that Ewsa 
regulates axis development through regulation of collagen2a1 expression, which in turn allows 
for normal notochord sheath ECM distribution, which in turn allows for notochord cell intercalation 
and later IVD and vertebral body formation. This is the first in vivo evidence for regulation of 
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 EWS (EWSR1, Ewing sarcoma breakpoint region 1) is a gene that was originally 
discovered in Ewing sarcoma (ES), the second most common bone cancer found in children and 
young adults. The hallmark of this disease is the presence of an aberrant fusion gene encoding 
the N-terminal transcriptional activation domain of EWS and the C-terminal domain of an ETS 
transcription factor, formed by a chromosomal translocation [1]. The most common fusion gene 
reported, EWS/FLI1, is known to drive aberrant transcription of target genes compared to cells 
not expressing EWS/FLI1 [2-4] and induces altered splicing events [5, 6].  EWS/FLI1 has also 
been shown to interact directly with EWS to inhibit its endogenous function in a dominant negative 
manner [7], and human cells with depleted EWS display mitotic defects, a phenotype similar to 
what is seen in cells expressing EWS/FLI1 [8]. This raises the possibility that EWS function may 
be inhibited in ES skeletal tumors due to the dominant activity of EWS/FLI1 on EWS. Therefore, 
elucidating the endogenous role of EWS in skeletal development is essential to understanding 
the pathogenesis of ES. 
 Evidence for a role of EWS in skeletal development was first demonstrated using EWS 
knockout mice, which display smaller size compared to wild-type littermates and decreased 
density of long bones and 90% postnatal lethality [9]. This study demonstrated that EWS plays a 
critical role during development, but the exact mechanism of EWS during skeletogenesis and long 
bone formation is not explained. The formation of long bones, the site of ES, develops through 
endochondral ossification (Fig. 1). The other processes of bone formation is intramembranous 
ossification, which occurs by direct ossification of mesenchymal precursors giving rise to bone. 
Endochondral ossification begins with the condensation of mesenchymal precursor cells. These 
condensations are first driven to the cartilage lineage and differentiate into proliferating 
chondrocytes via SOX9 (SRY, (Sex Determining Region Y) - box 9) activity [10].  Proliferating 
chondrocytes then undergo tightly controlled changes in gene expression and morphology to 
promote progression into intermediate prehypertrophic cells before differentiating into 
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hypertrophic cells, followed by mineralization of the extracellular matrix. The hypertrophic 
chondrocytes then secrete factors to induce angiogenesis which brings in osteoblasts and then 
undergo cell death before being replaced by bone deposited by osteoblasts.  
To increase our understanding of the in vivo role of EWS, we utilized zebrafish as a model. 
The two zebrafish orthologues of human EWS were first described as ewsr1a (ewsa) and ewsr1b 
(ewsb) [11]. Depletion of ewsa and ewsb via morpholino injection at the one-cell stage contributed 
to mitotic defects induced via multipolar and abnormal spindles, and embryos depleted of ewsa 
and ewsb also displayed a reduced number of proneural cells due to p53-mediated apoptosis in 
the central nervous system and embryonic lethality by 5dpf [11]. These initial results describe the 
essential role of ewsa and ewsb during development. To study the role of EWS during 
skeletogenesis, we obtained a maternal zygotic (MZ) ewsa/ewsa zebrafish line null for Ewsa. 
Zebrafish depleted of ewsb did not survive to adulthood. We have found that MZ ewsa/ewsa 
mutant fish display defects in cartilage structures including impaired differentiation of 
chondrocytes and aberrant angle of Meckel’s cartilage and palatoquadrate structures, 
emphasizing the role of EWS in skeletogenesis [12]. To explain this mechanism, in this same 
report [12], we demonstrated a role for EWS in chondrocyte development to regulate SOX9. 
The other essential transcription factor required for chondrogenesis is the skeletogenesis 
master transcription factor RUNX2 (Runt-related transcription factor 2). SOX9 is essential for 
driving cells into the chondrocyte lineage and preventing hypertrophy, but maturation of 
chondrocytes to hypertrophic chondrocytes is driven by RUNX2 and inhibited by SOX9 through 
direct inhibition of RUNX2 by SOX9 [13-15]. For the correct gene expression changes that take 
place during chondrocyte differentiation to occur, SOX9 activity must be inhibited and RUNX2 
activity must be promoted. In RUNX2-deficient mice, the skeletal structures consist of only resting 
and proliferating cartilage [16-18]. These mice also display postnatal lethality due to a complete 
lack of ossification due to the absence of mature osteoblasts [19] providing further evidence for 
the importance of RUNX2 during both chondrogenesis and skeletogenesis. Since Ewing sarcoma 
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occurs in skeletal tissue, we need to increase our understanding of the molecular mechanisms 
by which EWS directs chondrocyte maturation. Loss of Ewsa in fish contributes to defects in 
cartilage structures, and since Runx2 is required to drive cartilage differentiation, we seek to 
determine if regulation of RUNX2 occurs in zebrafish null for Ewsa. We then ask specifically how 
Ewsa regulates Runx2 and if this is done by controlling Runx2 mRNA transcription, Runx2 protein 
translation, and/or transcriptional activity of Runx2. We investigate how Ewsa regulates Runx2 
during chondrogenesis, and how this regulation influences the transcriptional profile of 
chondrocytes during differentiation. 
 During this study we also aimed to elucidate the function of Ewsa in axial skeletal 
formation. The axial skeleton is derived from the notochord, a critical structural component and 
signaling center in zebrafish. Preceding axis formation, the notochord must undergo vacuolization 
followed by secretion of extracellular matrix (ECM) proteins, notably type II collagen, to form the 
sheath surrounding the notochord. [20-22]. Also, the formation of the ECM is critical for proper 
development of the notochord and spine because notochord cells provide pressure on the sheath 
for support and provide the notochord with its structural properties [23]. The sheath itself is 
composed of both condensed and non-condensed areas. The condensed areas form the nucleus 
pulposus cells and the non-condensed areas give rise to sclerotome cells, the precursor of 
vertebral bodies [24]. Notochord cells located in vertebral bodies are then removed and relocate 
to intervertebral regions where they form the nucleus pulposus cells which then give rise to the 
intervertebral discs (IVD) [25, 26]. Sclerotome cells migrate around the notochord and undergo 
endochondral ossification to form the vertebrae [27]. Adult MZ ewsa/ewsa fish in our lab display 
aberrant curved spines likely due to a defect in IVD formation, impaired differentiation of nucleus 
pulposus cells, and overexpression of type II collagen in the notochord and ECM. These mutants 
also display premature vertebrae formation compared to wild-type. In Collagen II-deficient mice, 
the notochord persists as a rod-like structure in vertebral bodies until birth [28] providing evidence 
of the critical importance of Collagen II during axis formation. Our previous data suggest that 
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Ewsa is critical for formation of the axial skeleton possibly through regulation of type II collagen. 
It is unknown, however, how Ewsa-dependent regulation of the notochord sheath and ECM 
contributes to the development of the notochord. In this study we aim to elucidate the first steps 
of the mechanism underlying how the formation of the notochord is regulated by Ewsa to 
ultimately form the skeletal axis. Together, in this report we investigate how Ewsa regulates 
chondrogenesis through regulation of Runx2 expression as well as its role in axial skeletogenesis. 
 
MATERIALS & METHODS 
Zebrafish maintenance  
Zebrafish were bred and maintained at 28.5˚C using an automatic filtration system from Aquatic 
Eco-Systems Inc, and embryos were staged as previously described [29]. The wild type line used 
was the Oregon AB* line. The ewsa/ewsa line was generated by insertional mutagenesis in a 
wild-type Ekkwill (EK) background by Znomics Inc, and is maintained as a Maternal Zygotic (MZ) 
line in our system. 
 
Alizarin red staining  
Zebrafish were stained with alizarin red to stain skeletal structures as previously described [30]. 
Fish were anesthetized with 0.04% Tricaine Methanesulfonate (MS222) and fixed overnight at 
4˚C in 4% paraformaldehyde. Pigment was ablated by treatment with 3% H2O2 in 1% KOH. 
Cleared specimens were stained with 0.05% alizarin red dissolved in 1% KOH, destained with 
successive washes of glycerol/0.25% KOH, and stored in glycerol. Images were taken with a 
Leica DFC320 camera mounted on a Leica MZ FLIII dissecting microscope. 
 
Immunohistochemistry  
Embryos were visualized as previously described [11]. Fixed embryos were permeabilized with 
methanol at -20˚C overnight, digested with 0.01% trypsin, and then blocked with blocking solution 
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(5% fetal bovine serum, 0.1% tween-20, in PBS (phosphate buffered saline)). Primary antibodies 
were applied overnight at 4˚C; embryos were washed thoroughly in wash solution (0.1% tween-
20 in PBS); and secondary antibodies were applied overnight at 4˚C. Embryos were then washed 
thoroughly again. We used a rabbit polyclonal primary antibody (LS-C47340 from LS-Bio) diluted 
1:100 and anti-rabbit Alexa 488 diluted 1:250 to visualize Runx2. We used an anti-rabbit 
polyclonal anti-Collagen X primary antibody (ab58632, abcam) diluted 1:100 and anti-rabbit Alexa 
488 diluted 1:250 to visualize Collagen X. We used a solution of WGA (wheat germ agglutinin) 
Alexa 594 or Alexa 488 diluted 5 µg/mL to visualize cartilage and DAPI diluted 0.5 mg/mL to 
visualize DNA. Images were taken with an Exi Aqua camera (Q Imaging) mounted on an Eclipse 
Ti microscope (Nikon). 
 
In situ hybridization 
In situ hybridization was performed as previously described (Azuma et al, 2006). Fixed embryos 
were permeabilized in methanol at -20˚C overnight then washed in PBS. Embryos were then 
equilibrated in hybridization (HYB) buffer at 60˚C for 3 hours. Embryos were then hybridized 
overnight at 60˚C with antisense RNA generated with T7 RNA polymerase and DIG-labeled 
dUTP. Embryos were then treated with anti-DIG antibodies conjugated with alkaline phosphatase 
(AP) overnight at 4˚C. After equilibration with AP buffer, signal was developed with BM Purple to 
detect presence of runx2bP2 mRNA, and then embryos were fixed again in 4% paraformaldehyde 
at room temperature for 10 minutes. Statistical analysis was performed scoring the embryo as 
either normal or overexpressed using the Chi-square test with one degree of freedom (wt/wt, 






Runx2 protein expression is upregulated in craniofacial cartilage structures in MZ 
ewsa/ewsa mutant fish 3-6dpf. In Ewing sarcoma, pathogenesis of the disease occurs in bone 
and soft tissue and as a result of the dominant negative function of EWS/FLI1 over EWS [7]. As 
a result, understanding the role for Ewing sarcoma protein EWS in the regulation of 
skeletogenesis is of interest. We have shown previously that Ewsa regulates chondrogenesis 
through control of chondrogenesis master transcription factor Sox9 and regulates expression of 
its target genes [12]. The other major transcription factor involved in this process is RUNX2 (Runt-
related transcription factor 2), the master transcription factor of skeletogenesis and 
osteoblastogenesis. During the initial stages of chondrogenesis, SOX9 drives mesenchymal 
condensations to the chondrocyte lineage and to proliferate [31, 32] and RUNX2 drives 
chondrocytes to differentiate from prehypertrophy to hypertrophy [16, 17]. We wanted then to 
understand how expression of Runx2 protein is regulated by Ewsa during zebrafish chondrocyte 
maturation. In zebrafish, due to a genome duplication event, runx2 exists as two orthologues, 
runx2a and runx2b [33, 34]. Earlier in situ hybridization studies have shown that runx2a is 
expressed in zebrafish by the 70% epiboly stage and runx2b mRNA is expressed as early as the 
one-cell stage [33]. Even though both runx2a and runx2b are detected in early stages, the role of 
Ewsa in regulation of Runx2 protein expression in later stages during chondrocyte maturation 
remains unknown. To understand how the dynamics of Runx2 protein expression is regulated by 
Ewsa during the period of chondrocyte maturation we utilized a commercially available RUNX2 
antibody (LSBio LS-C47340). The CBFA1/RUNX2 antibody used in this study was raised in rabbit 
against a peptide that corresponds to amino acids 262-279 of human RUNX2. BLAST analysis of 
the immunogen sequence confirms 88% identify with zebrafish Runx2a and Runx2b. Therefore, 
it is possible the signal seen in embryos using this antibody is both Runx2a and Runx2b. This 
antibody recognizes the C-terminus of Runx2 to avoid cross-reactivity with the RUNX1 and 
RUNX3, the other two members of the RUNX gene family which all contain the homologous Runt 
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DNA-binding domain. Wild-type (wt/wt) and MZ ewsa/ewsa mutant embryos at 3dpf were 
subjected to immunohistochemistry using a 1:100 dilution of anti-RUNX2 antibody (Fig. 2). Wild-
type embryos at this stage did not express detectable levels of Runx2 protein in the Meckel’s 
cartilage, a structure that undergoes endochondral ossification. At this same stage, MZ 
ewsa/ewsa mutant embryos expressed Runx2 in a greater number of chondrocytes in the 
Meckel’s cartilage compared to wild-type embryos. This trend was also seen in another 
endochondral cartilage domain, the ceratohyal, at this stage (Fig. 18). To further investigate the 
dynamics of Runx2 expression in later stages of chondrocyte maturation, wild-type and MZ 
ewsa/ewsa embryos were subject to immunohistochemistry with Runx2 antibody from 4-6dpf. In 
the MZ ewsa/ewsa embryos, the pattern of Runx2 overexpression was continued in the Meckel’s 
cartilages compared to the wild-type (Fig. 3). During these same stages, other craniofacial 
cartilage domains in MZ ewsa/ewsa embryos also displayed an increase of Runx2 expression 
including the ceratohyal (Fig. 19), palatoquadrate (Fig. 20), hyomandibular (Fig. 21), and ethmoid 
plate (Fig. 4, Fig. 5). This data suggests that Ewsa plays a role in inhibiting either the transcription 
of runx2 or Runx2 translation during these stages of chondrocyte development. 
 
Ewsa does not regulate transcription of runx2 mRNA in all craniofacial domains. To validate 
expression of Runx2 protein, in situ hybridization using antisense RNA probes specific to 
runx2aP2 isoform was performed using 4dpf wt/wt and MZ ewsa/ewsa embryos (Fig. 6). 
Expression of runx2b has been described previously using in situ hybridization [35], and 
expression of runx2b using our probe matches the results described in the literature in the ethmoid 
plate. Interestingly, over-expression of runx2bP2 only occurred in the ethmoid plate and not the 
Meckel’s cartilage of MZ ewsa/ewsa embryos suggesting a domain-specific regulation of 
runx2bP2 transcription by Ewsa. There is no change in expression of runx2bP2 mRNA transcript 
in the Meckel’s cartilage, ceratohyal, or other craniofacial cartilage domains at this time even 
though Runx2 protein expression was previously shown to be increased in these domains at 4dpf. 
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Expression of Collagen X is misregulated in craniofacial structures in MZ ewsa/ewsa fish. 
Ewing sarcoma is a disease characterized as small round blue cells, which is indicative of an 
undifferentiated phenotype. To further understand how Ewsa plays a role in differentiation of 
chondrocytes, the differentiation profile of chondrocytes was examined in wt/wt and MZ 
ewsa/ewsa fish. The protein expression profile of structural protein collagen, type X, α1 (Col10a1) 
a late hypertrophic chondrocyte marker, was studied in wt/wt and MZ ewsa/ewsa fish from at 5dpf. 
We have also previously shown that expression of Col10a1 protein, a known Runx2 target gene 
[36], is downregulated in MZ ewsa/ewsa fish at 5dpf [12]. These previous data provide further 
evidence that differentiation of chondrocytes is inhibited at these early stages of development in 
MZ ewsa/ewsa mutants.  
Runx2 has been shown to be one of the main drivers of differentiation of 
prehyperchondrocyte differentiation into hypertrophic chondrocytes and endochondral 
ossification [17, 37]. Since Runx2 has roles in both chondrocyte and osteoblast differentiation, 
Runx2 is an attractive target for Ewsa regulation. To understand if Ewsa regulates one of the 
hypertrophic chondrocyte-specific downstream target genes of Runx2, Collagen X, embryos were 
subjected to immunohistochemistry from 5dpf using Collagen X antibodies. At 5dpf, MZ 
ewsa/ewsa embryos do not display detectable levels of Collagen X signal in Meckel’s cartilage 
(Fig. 10), as well as another cartilage domain, ceratohyal (Fig. 22). This is indicated by a decrease 
in signal intensity within these structures compared to wt/wt, which shows Collagen X signal within 
chondrocytes. Interestingly, the hyomandibular cartilage at this stage displays an increase in 
Collagen X signal at 5dpf (Fig. 23) which may suggest domain-specific regulation of Runx2 
transcriptional activity occurs. These data suggest that one of the possible mechanisms by which 
Ewsa drives chondrocyte differentiation is through regulation of expression of Collagen X, 




Mineralization of craniofacial structures is increased in MZ ewsa/ewsa mutant fish. We 
examined if the final stages of skeletogenesis, deposition of mineralized matrix, is regulated by 
Ewsa. wt/wt and MZ ewsa/ewsa embryos were subjected to alizarin red staining to detect 
mineralization in craniofacial domains in 6dpf and 10dpf embryos. At 6dpf, MZ ewsa/ewsa 
embryos show increased intensity of Alizarin red stain compared to wt/wt in the parasphenoid (ps) 
region (Fig. 7). At this stage, mineralization has not yet begun of the endochondral structures, 
such as Meckel’s cartilage and ceratohyal. At 10dpf MZ ewsa/ewsa shows greater mineralization 
in the ps, dentary (d), ceratohyal (ch), and vertebrae (Fig. 8, Table 1). This data matches the 
results seen in chondrocytes overexpressing Runx2. The dentary, which forms around the 
Meckel’s cartilage, shows an increased expression of mineralization compared to wt/wt. The 
ceratohyal, also displays premature endochondral ossification as does the parasphenoid, a 
domain near where Runx2 is overexpressed in the ethmoid plate. Premature vertebrae formation, 
which arise from endochondral ossification, also occurs in MZ ewsa/ewsa mutants. A possible 
explanation for this is that premature overexpression of Runx2 in these domains is inducing 
premature mineralization. A similar phenotype has been reported in which mice with chondrocyte-
specific overexpression of Cbfa1/Runx2 under the control of the type II collagen gene promoter 
have shown premature chondrocyte maturation and endochondral ossification [38]. This is slightly 
different than what occurs in our MZ ewsa/ewsa fish. Our results suggest that mutants show 
delayed chondrocyte differentiation in the endochondral structure Meckel’s cartilage but show an 
increase of mineralization in the parasphenoid structure and the dentary, ceratohyal, and 
vertebrae. There could be several reasons for this difference. First, Runx2 was only 
overexpressed in cartilage cells in mice whereas in MZ ewsa/ewsa fish, there is a loss of Ewsa in 
the entire organism which may misregulate the function of the osteoblast that deposit mineralized 
matrix. Also, in mutant fish we have shown an increase of Indian Hedgehog (Ihh) expression in 
the chondrocytes of the Meckel’s cartilage, and Ihh has been shown to prevent chondrocyte 
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hypertrophy [39]. The overexpression of Ihh may be contributing to delayed differentiation while 
osteoblast function may be misregulated, leading to premature mineralization.  
 
Notochord cells fail to intercalate and expression of Runx2 is misregulated in the body of 
MZ ewsa/ewsa embryos. Ewing sarcoma development occurs in skeletal elements such as the 
spine, so we aimed to elucidate the role of Ewsa in axial development. In vertebrates, the 
notochord gives rise to the nucleus pulposus cells and intervertebral discs in the axial skeleton. 
MZ ewsa/ewsa adult fish show curved spines compared to wt/wt. To understand the mechanism 
behind this phenotype, notochord cells were visualized in live embryos from 5, 6, 8 and 10dpf 
using brightfield microscopy. The notochord cells of wt/wt embryos at 5dpf (data not shown) and 
at 6dpf intercalate whereas notochord cells of MZ ewsa/ewsa mutant zebrafish are more narrow 
and stacked in a single row (Fig. 11). This trend continued throughout 8dpf and 10dpf (Fig. 24). 
The cell margins of the notochord cells also appear thicker in MZ ewsa/ewsa embryos compared 
to wt/wt. These data suggest that Ewsa plays a critical role in the organization of notochord cells. 
We have shown previously that MZ ewsa/ewsa mutant zebrafish have curved spines, 
which may suggest a misregulation of skeletogenesis in this process. We have already seen that 
Ewsa regulates the expression of Runx2 in craniofacial cartilage, so next we wanted to investigate 
the possible role of Ewsa-dependent regulation of Runx2 in notochord development. Embryos at 
3dpf were subjected to immunohistochemistry using anti-Runx2 antibodies at a 1:100 dilution. At 
3dpf, interestingly, Runx2 expression is decreased in the posterior region of the tail inside the 
notochord of MZ ewsa/ewsa mutants compared to wt/wt embryos (Fig. 12, Fig. 13). By 5dpf (Fig. 
14, Fig. 15) and 6dpf (Fig. 16, Fig. 17) Runx2 protein expression in wt/wt embryos extends 
anteriorly while Runx2 expression in MZ ewsa/ewsa mutants remains more posteriorly localized. 
These data suggest that Ewsa is required for promoting the temporal expression and localization 
of Runx2 in the notochord. This leads us to speculate that Ewsa’s regulation of the localization of 
Runx2 may also affect the localization and expression of Runx2’s downstream target genes, such 
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as col10a1, in these domains. Future study will focus on elucidating how expression of Runx2 
target genes are regulated by Ewsa in this domain, since formation of vertebral bodies occurs 
through an endochondral process, of which Runx2 is an essential component. Col10a1 has 
already been shown to be expressed premature to vertebral body formation [26] so misregulation 
of Runx2 expression in these domains may contribute to aberrant Col10a1 expression. 
Misregulation of this process may lead to aberrant vertebral skeletogenesis and the development 
of curved spines in MZ ewsa/ewsa embryos. 
 
DISCUSSION 
Ewsa regulates craniofacial skeletogenesis through regulation of Runx2 
To understand the role of Ewsa during skeletogenesis, we investigated the effect of Ewsa 
on the master regulator of skeletogenesis, Runx2. Our results indicate that Ewsa plays a critical 
role in controlling expression of Runx2 protein and its target gene col10a1 and regulating 
mineralization of craniofacial domains. Together we propose that Ewsa regulates chondrogenesis 
through regulation of Runx2 expression and transcriptional activity (Fig. 9).  
Previous work in this lab has shown that Ewsa plays a critical role in regulating 
chondrocyte maturation through modulation of the chondrogenesis master transcription factor 
Sox9 and its transcriptional targets in association with skeletal defects [12]. The other critical 
transcription factor that drives cartilage differentiation is RUNX2. Tightly regulated control of 
RUNX2 activity is required to ensure that premature differentiation of chondrocytes and 
subsequent mineralization does not occur resulting in severe bone defects. This regulation is 
done partly through SOX9, which has a dominant role on RUNX2 during chondrogenesis [14]. 
Therefore, controlling the timing of SOX9 and RUNX2 activity is critical for proper cartilage and 
skeletal development. Since we have shown that EWS directly interacts with SOX9 [12], it is 
possible that EWS inhibits regulation of RUNX2 through SOX9. Currently, the role of EWS in 
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RUNX2 regulation has only been described in vitro [40]. Elucidating the role of EWS in regulation 
of RUNX2 in vivo is of critical importance. 
This report is the first in vivo study of EWS-dependent regulation of RUNX2. We first 
investigated if Runx2 protein levels were affected during chondrocyte differentiation. Here we 
report that Runx2 protein expression is highly increased in craniofacial chondrocytes of MZ 
ewsa/ewsa fish. These data suggest that Ewsa is essential for controlling the timing of Runx2 
protein expression in these domains by inhibiting expression of Runx2. Since in situ hybridization 
only showed an increase of runx2 mRNA expression in the ethmoid plate domain and not at the 
Meckel’s cartilage or other endochondral structures, these data may suggest that Ewsa does not 
inhibit Runx2 through transcriptional inhibition in the Meckel’s cartilage but through another 
mechanism. One possible explanation is that Runx2 may be inhibited by Sox9 in these domains. 
SOX9 has been shown to inhibit RUNX2 function [14] as well as direct it to the lysosome for 
degradation [15]. It is possible that since Ewsa regulates Sox9 function, Ewsa may be working 
through Sox9 to inhibit Runx2 protein expression in prehypertrophic chondrocytes to prevent 
premature differentiation. Previous data in our lab has shown that Sox9a protein is expressed in 
cartilage structures and this expression is unchanged in both wt/wt and MZ ewsa/ewsa from 3-
6dpf [41], whereas Runx2 is inhibited in wt/wt during this period and upregulated in MZ ewsa/ewsa 
mutants. This suggests that Sox9a is unable to inhibit Runx2 expression in these domains in the 
absence of Ewsa. To understand if Ewsa is required for Sox9-dependent Runx2 inhibition, it will 
be interesting to study further if loss of Ewsa also contributes to a decrease in lysosomal activity 
in chondrocytes, since SOX9 directs RUNX2 towards lysosomal degradation. Alternatively, Ewsa 
may be required to bind to runx2 mRNA to prevent premature translation [33, 34]. Consistent to 
the upregulation of Runx2, we also discovered that mineralization of craniofacial structures of MZ 
ewsa/ewsa fish is increased compared to wt/wt. These data suggest that Ewsa may work through 
Sox9 to inhibit Runx2 protein to regulate the timing of mineralization. In the absence of Ewsa, 
overexpression of Runx2 in cartilage domains may contribute to the phenotype of premature 
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mineralization, possibly by no longer inhibiting Runx2 expression through Sox9. This is notable 
because in previous reports, tissue-specific overexpression of Runx2 in mice prehypertrophic 
chondrocytes led to premature and increased mineralization of long bones and stunted growth 
[38]. In future studies it will be interesting to identify key signaling molecules in the 
microenvironment of cartilage structures that may be overexpressed in response to 
overexpression of Runx2 in chondrocytes, such as Bone morphogenic protein (BMP) and 
Parathyroid-related peptide (PTHrP). Another possibility is that the premature mineralization 
phenotype is due to the overexpression of another signaling molecule not directly related to Runx2 
overexpression, but another molecule overexpressed due to loss of Ewsa. In MZ ewsa/ewsa 
mutants, we have previously shown that expression of Ctgf is increased in craniofacial domains 
compared to wt/wt. Ctgf is also a known driver for mineralization [42], so Ctgf overexpression may 
work in parallel with Runx2 overexpression to drive premature mineralization. To test this 
hypothesis, in future studies we will knock out both ctgf and runx2 in zebrafish chondrocytes and 
observe whether this loss will rescue the mineralization phenotype.  
 
Ewsa regulates collagen10a1 expression through modulation of Runx2 transcriptional 
activity 
We discovered that col10a1 (colX) is decreased both at the mRNA and protein level in MZ 
ewsa/ewsa mutant compared to wt/wt embryos. The decrease was originally discovered in the 
Meckel’s cartilage.  In this study, we further discovered that there are also decreases in colX 
mRNA and protein in other craniofacial domains. Together, these results suggest that Ewsa is 
required for expression of ColX through regulation of Runx2’s transcriptional activity. Runx2 
overexpression has been shown to correlate with increased expression of colX [38]. Since Runx2 
overexpression in MZ ewsa/ewsa fish did not correlate with an increase in ColX expression, this 
suggests that Ewsa is also required for proper Runx2 transcriptional activity. Since ColX is also a 
marker for hypertrophic chondrocytes, this decrease in expression of ColX indicates that 
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differentiation of chondrocytes is impaired. For prehypertrophic chondrocytes to differentiate into 
hypertrophic chondrocytes, expression of colX by Runx2 is critical [36]. Since 
immunohistochemistry analysis only provides information of protein expression and localization, 
it is still uncertain how Ewsa can specifically be associated with Runx2 to drive transcription of its 
target genes. Previously, it’s been reported that EWS is associated with transcriptional coactivator 
p300/CBP to regulate transcription and chromatin remodeling [43, 44]. Runx2 has also been 
shown to interact with p300/CBP to drive expression of its target genes [45]. These reports 
combined indicate that it is possible that Runx2, EWS, and p300/CBP may form a complex for 
Runx2 to drive transcription of colX. For future studies, it will be interesting to understand if Ewsa 
forms a complex with p300/CBP and Runx2 to drive target gene expression in chondrocytes. 
Quantifying gene expression changes using quantitative RT-PCR and RNA-sequencing from 
cDNA generated using chondrocyte mRNA from wt/wt and MZ ewsa/ewsa mutants will also 
provide insight into changes of the transcriptional profile of Runx2 with and without Ewsa. 
Additionally, in a previous report and data not shown we have demonstrated that Ewsa binds to 
ctgf and col2a1 loci, and this binding suggests a possible mechanism for transcriptional regulation 
through chromatin remodeling. It will also be interesting to explore how Ewsa is required in 
chromatin remodeling for controlling expression of runx2 and its target gene loci, possibly through 
recruitment of transcriptional coactivators p300/CBP.   
 
Ewsa is required for proper formation of the notochord and vertebrae formation 
In addition to craniofacial structures, we looked at how Ewsa regulates formation of the 
axial skeleton, because Ewing sarcoma develops in skeletal elements. Previous data from our 
lab have shown that adult MZ ewsa/ewsa fish have curved spines, indicative of defects in the 
development of their axial skeleton. In zebrafish, a Notch-dependent event occurs that 
differentiates notochord cells into two distinct cell populations by 16.5 hours post-fertilization (hpf), 
and at this time the early notochord cells differentiate to form an outer sheath layer and an inner 
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layer composed of vacuolated cells [22]. The developing notochord depends upon both the rigidity 
of the extracellular matrix of the notochord sheath as well as the osmotic pressure the vacuolated 
cells exert on the sheath for structural support [46]. Previous data (not shown) from our lab have 
shown that Ewsa drives expression of type II collagen in the notochord, and in MZ ewsa/ewsa 
mutants type II collagen expression is upregulated compared to wt/wt.  We have previously shown 
via ChIP assay that Ewsa regulates Collagen II expression by interacting with the col2a1a locus. 
Collagen II is a critical component of axial skeleton formation; previous studies utilizing Col2a1-
null mice have shown that the notochord persists and IVD formation is inhibited [28]. In this study 
we found that at 5-6dpf and at 8dpf and 10dpf vacuolated notochord cells display defects in 
intercalation, evidenced by the single line stacking of vacuolated cells in notochords of MZ 
ewsa/ewsa. One possible explanation for this failure to intercalate is the evidence that increased 
expression of type II collagen in the sheath may be increasing the rigidity of the ECM. Thus, this 
rigidity may prevent the vacuolated cells from properly intercalating. Since the notochord cells 
serve as the foundation for nucleus pulposus cells that later form the IVDs, this phenotype may 
contribute to the downstream phenotype of adult MZ ewsa/ewsa fish displaying curved spines.  
As the notochord develops, it undergoes a process very similar to endochondral 
ossification. The notochord becomes segmented and in regions of vertebrae, expresses type X 
Collagen, which is eventually replaced by bone, while intervertebral discs are formed from 
notochord cells [26]. However, the overall development of this process is not well understood. 
Consistent with results from the cranial skeleton, we discovered that the mineralization of 
vertebrae occurs prematurely in MZ ewsa/ewsa embryos.  The result suggests the importance of 
Ewsa in the mineralization of the axial skeleton. One possible explanation for this result is that 
overexpression of Runx2 in this region is driving premature mineralization of the axis as well. 
Since expression of Runx2 target gene osteocalcin (osc) occurs in the sheath before 
mineralization [21], overexpression of Runx2 may be contributing to overexpression of 
Osteocalcin, driving premature mineralization. As a result, it is possible that Ewsa contributes to 
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mineralization by tightly regulating the formation of both the notochord sheath and expression of 
genes involved in mineralization. It is currently unknown how the organization of the ECM 
environment contributes to vertebrae formation. In future studies we will explore how the 
notochord ECM is misregulated in MZ ewsa/ewsa using electron microscopy. A misregulated 
ECM structure may contribute to the accumulation of several signaling molecules, such as Indian 
hedgehog (IHH) [47, 48], Bone morphogenic protein (BMP) [48] or other unidentified molecules, 
contributing to premature mineralization of vertebrae. To test this hypothesis, future work will 
elucidate the expression profile of these signaling models in the notochord and perform 
phenocopy experiments either over-expressing or down-regulating expression of signaling 
molecules contributing to premature vertebral mineralization. 
Among the domains in which Runx2 expression is dependent upon Ewsa regulation, it is 
of utmost importance to identify the exact mechanism behind which Ewsa inhibits Runx2 
expression, and how Ewsa regulates the expression of Runx2 target genes, particularly those 
involved in differentiation such as col10a1. Here we provide novel in vivo evidence of Ewsa-
dependent regulation of Runx2 in endochondral ossification. Since Ewing sarcoma is classified 
as an undifferentiated small round blue cell tumor, understanding the role of endogenous EWS in 
differentiate of skeletal tissue, the tissue in which Ewing sarcoma arises, will increase our 
understanding of the pathogenesis of the disease when EWS function is inhibited. Since RUNX2 
is critical for differentiation of chondrocytes, expanding our knowledge of the specific role EWS 
has on the function and expression of RUNX2 will increase our understanding of the pathogenesis 
of Ewing sarcoma and skeletogenesis, since defects in differentiation of this tissue type is 
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Figure 1. Endochondral ossification. Endochondral ossification is the 
developmental process of the formation of long bones that relies on a cartilaginous 
intermediate. Mesenchymal precursors differentiate into proliferating chondrocytes, 
which then differentiate into prehypertrophic chondrocytes and later hypertrophic 
chondrocytes. Hypertrophic chondrocytes then construct ECM and die and become 





Figure 2. Runx2 is expressed in Meckel’s cartilage of 3dpf MZ ewsa/ewsa embryos but 
not wt/wt. Immunohistochemistry of wild-type (wt/wt) and maternal zygotic (MZ) ewsa/ewsa 
Meckel’s cartilage at 3dpf with RUNX2 antibody. Runx2 protein is not expressed at detectable 
levels in wt/wt embryos but is expressed in a higher number of chondrocytes in MZ ewsa/ewsa 
mutants at 3dpf. Antibody dilution 1:100. wt/wt n=8; MZ ewsa/ewsa n=10 (p<0.001, Chi-square 




Figure 3: Runx2 expression in wild-type and MZ ewsa/ewsa Meckel’s cartilage from 4-
6dpf.  Immunohistochemistry of wild-type (wt/wt) and maternal zygotic (MZ) ewsa/ewsa mutant 
embryos with RUNX2 antibody shows that expression of Runx2 protein is present in the 
Meckel’s cartilage at 4-6dpf. Structures were scored as either ‘overexpression’ or ‘low 
expression’ of Runx2. At 4dpf, 2/27 (7%) wt/wt embryos (n=27) display overexpression and 
40/41 (98%) of MZ ewsa/ewsa zebrafish display overexpression of Runx2 (p<0.005). At 5dpf, 
1/10 (10%) wt/wt embryos showed strong expression and 11/11 (100%) MZ ewsa/ewsa 
embryos showed high expression of Runx2 (p<0.001). At 6dpf 0/8 (0%) wt/wt embryos (n=8) 
display overexpression and 8/8 (100%) of MZ ewsa/ewsa embryos (n=8) display 
overexpression. Statistical analysis performed using Chi-square test with one degree of 





Figure 4. Runx2 expression in wild-type and MZ ewsa/ewsa craniofacial cartilage from 
4dpf.  Immunohistochemistry of wild-type (wt/wt) and maternal zygotic (MZ) ewsa/ewsa 
mutant embryos with RUNX2 antibody shows that expression of Runx2 protein is present in a 
higher number of chondrocytes of ethmoid plate at 4pf in MZ ewsa/ewsa zebrafish compared 





Figure 5: Runx2 expression in wild-type and MZ ewsa/ewsa ethmoid plate from 5dpf.  
Immunohistochemistry of wild-type (wt/wt) and maternal zygotic (MZ) ewsa/ewsa mutant 
embryos with RUNX2 antibody shows that expression of Runx2 protein is present in a higher 
number of chondrocytes of the ethmoid plate at 5-6dpf in MZ ewsa/ewsa zebrafish compared 
to wt/wt embryos. Antibody dilution 1:100. 
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  Figure 6. Expression of runx2bP2 transcripts increased in MZ ewsa/ewsa mutants. In 
situ hybridization using an anti-sense runx2bP2 isoform probe shows increased expression in 
the ep region but not in Meckel’s cartilage. wt/wt n=13; MZ ewsa/ewsa, n=18. 56% (10/18) MZ 
ewsa/ewsa embryos showed increased expression in ep compared to wt/wt (p<0.001, Chi-





Figure 7. Mineralization is increased in MZ ewsa/ewsa embryos compared to wt/wt at 
6dpf. Alizarin red staining shows an increase of mineralization in the MZ ewsa/ewsa embryos. 
Embryos were scored as having either a high or low amount of mineralization indicated by 
more intense signal and extended anteriorly. 0/8 (0%) of wt/wt embryos (n=8) displayed high 
mineralization and 9/9 (100%) MZ ewsa/ewsa embryos (n=9) displayed high degrees of 
mineralization (p<0.001). Statistical analysis performed using Chi-square test with one degree 





Table 1: % of craniofacial structures displaying high mineralization at 10dpf 
 d ps ch v n= 
wt/wt 0/8 (0%) 0/8 (0%) 0/8 (0%) 0/8 (0%) 8 
MZ ewsa/ewsa 9/9 (100%)* 9/9 (100%)* 9/9 (100%)* 9/9 (100%)** 9 
*p<0.001, **p<0.05 
Figure 8. Mineralization is increased in MZ ewsa/ewsa embryos compared to wt/wt at 
10dpf. Alizarin red staining shows an increase of mineralization in the MZ ewsa/ewsa 
embryos. wt/wt, n=8; MZ ewsa/ewsa, n=9. 4/9 MZ ewsa/ewsa displayed vertebrae. 




Figure 9. Model of Ewsa-Runx2 modulation in skeletogenesis. In early proliferating and 
prehypertrophic chondrocytes, Sox9 is the dominant transcription factor, and heterodimerizes 
with Ewsa to regulate transcription of its target genes. In these early chondrocytes, Sox9 has 
a dominant negative function on Runx2 and directs its degradation toward the lysozome. Sox9 
protein expression levels are the same from 3-6dpf in both wt/wt and MZ ewsa/ewsa (data not 
shown). In wt/wt, this corresponds with a decrease in Runx2 expression at this time. In MZ 
ewsa/ewsa chondrocytes Runx2 expression remains increased, suggesting that Sox9 




Figure 10. Collagen10a1 expression is decreased in Meckel’s cartilage of MZ ewsa/ewsa 
mutant embryos compared to wt/wt at 5dpf. Ventral views of Meckel’s cartilage of 5dpf 
wt/wt and MZ ewsa/ewsa mutant embryos (anterior to left) visualized by 
immunohistochemistry using anti-Collagen10a1 antibodies (green) and cartilage stain WGA 
(red). Meckel’s cartilages were scored as either ‘expressing’ ColX or ‘not expressing’ ColX. 
4/4 (100%) of wt/wt embryos (n=4) expressed ColX and 0/6 (0%) of MZ ewsa/ewsa embryos 
(n=6) expressed ColX (p<0.005). Statistical analysis performed using the Chi-square test and 






Figure 11. Notochord cells fail to intercalate in MZ ewsa/ewsa mutants compared to 
wt/wt. Brightfield analysis of the notochord cells of 6dpf embryos. MZ ewsa/ewsa mutants 
show thicker notochord boundaries and fewer intercalated cells. Magnification 200x. 0% of 





  Figure 12. Runx is expressed in the posterior tail at 3dpf. Runx2 is expressed inside the 





Figure 13. Runx2 expression is decreased in the posterior tail of 3dpf MZ ewsa/ewsa 
mutants compared to wt/wt. Runx2 is expressed inside the notochord in the posterior portion 
of the tail in MZ ewsa/ewsa mutants, but at a decreased intensity compared to wt/wt. Posterior 




Figure 14. Runx2 expression extends more anterior at 5dpf. Runx2 is expressed inside 
the notochord in the posterior portion of the tail and expression begins extending anteriorly at 




Figure 15. Runx2 expression in the MZ ewsa/ewsa mutants remains decreased in the 
posterior portion of the tail by 5pdf compared to wt/wt. Runx2 is expressed inside the 
notochord in the posterior portion of the tail and expression remains decreased compared to 





Figure 16. Runx2 expression extends more anterior at 6dpf. Runx2 is expressed inside 
the notochord in the posterior portion of the tail and expression continues extending anteriorly 




Figure 17. Runx2 expression extends more anterior at 6dpf. Runx2 is expressed inside 
the notochord in the posterior portion of the tail and expression begins extending anteriorly at 





Figure 18. Runx2 is expressed in ceratohyal cartilage of 3dpf MZ ewsa/ewsa embryos 
but not wt/wt. Immunohistochemistry of wild-type (wt/wt) and maternal zygotic (MZ) 
ewsa/ewsa ceratohyal cartilage at 3dpf with RUNX2 antibody. Runx2 protein is not expressed 
at detectable levels in wt/wt embryos but is expressed in a higher number of chondrocytes in 




Figure 19: Runx2 expression in wild-type and MZ ewsa/ewsa ceratohyal from 4-6dpf.  
Immunohistochemistry of wild-type (wt/wt) and maternal zygotic (MZ) ewsa/ewsa mutant 
embryos with RUNX2 antibody shows that expression of Runx2 protein is present in the 
ceratohyal of 4dpf MZ ewsa/ewsa zebrafish but not wt/wt embryos.  Expression of Runx2 
persists through 6dpf, with a greater number of chondrocytes expressing Runx2 in MZ 




Figure 20: Runx2 expression in wild-type and MZ ewsa/ewsa craniofacial cartilage from 
5-6dpf.  Immunohistochemistry of wild-type (wt/wt) and maternal zygotic (MZ) ewsa/ewsa 
mutant embryos with RUNX2 antibody shows that expression of Runx2 protein is present in a 
higher number of chondrocytes of the palatoquadrate cartilage at 5-6dpf in MZ ewsa/ewsa 




Figure 21: Runx2 expression in wild-type and MZ ewsa/ewsa craniofacial cartilage from 
5dpf.  Immunohistochemistry of wild-type (wt/wt) and maternal zygotic (MZ) ewsa/ewsa 
mutant embryos with RUNX2 antibody shows that expression of Runx2 protein is present in a 
higher number of chondrocytes of the hyomandibular cartilage at 5-6dpf in MZ ewsa/ewsa 




Figure 22. Collagen10a1 expression is decreased in ceratohyal of MZ ewsa/ewsa 
mutant embryos compared to wt/wt at 5dpf. Ventral views of ceratohyal of 5dpf wt/wt and 
MZ ewsa/ewsa mutant embryos (anterior to left) visualized by immunohistochemistry using 










Figure 23. Collagen10a1 expression is similar in hyomandibular of MZ ewsa/ewsa 
mutant embryos compared to wt/wt at 5dpf. Ventral views of ceratohyal of 5dpf wt/wt and 
MZ ewsa/ewsa mutant embryos (anterior to left) visualized by immunohistochemistry using 






Figure 24. Notochord cells fail to intercalate in MZ ewsa/ewsa mutants compared to 
wt/wt. Brightfield analysis of the notochord cells of 8dpf and10dpf embryos. MZ ewsa/ewsa 
mutants show thicker notochord boundaries and fewer intercalated cells. Magnification 200x. 
